Detalles de la búsqueda
1.
International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials.
Am J Respir Crit Care Med
; 206(1): 25-33, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35363593
2.
Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review.
Am J Respir Crit Care Med
; 203(6): 689-698, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32966751
3.
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort.
Eur Respir J
; 57(3)2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33303557
4.
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med
; 201(12): 1508-1516, 2020 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162970
5.
Adjudication of cardiovascular events in patients with chronic obstructive pulmonary disease: SUMMIT trial.
Clin Trials
; 17(4): 430-436, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32441114
6.
A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD.
BMC Pulm Med
; 20(1): 119, 2020 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32366249
7.
Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD.
Respir Res
; 20(1): 86, 2019 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31068182
8.
Improving the Affordability of Prescription Medications for People with Chronic Respiratory Disease. An Official American Thoracic Society Policy Statement.
Am J Respir Crit Care Med
; 198(11): 1367-1374, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30601674
9.
Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.
Am J Respir Crit Care Med
; 198(1): 51-57, 2018 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29442524
10.
Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk.
Am J Respir Crit Care Med
; 197(1): 47-55, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28737971
11.
Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial.
Eur Heart J
; 39(33): 3128-3134, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30101300
12.
Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction.
Am J Respir Crit Care Med
; 195(7): 881-888, 2017 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27767328
13.
Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial.
Lancet
; 387(10030): 1817-26, 2016 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27203508
14.
Mortality after admission with pneumonia is higher than after admission with an exacerbation of COPD.
Eur Respir J
; 59(5)2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35273031
15.
FEV1 Minimum Important Difference versus Minimal Detectable Difference? In Search of the Unicorn.
Am J Respir Crit Care Med
; 203(12): 1573-1576, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33751925
16.
Reply to Fisk and Wilkinson: Aortic Pulse Wave Velocity Predicts All-Cause Mortality in Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med
; 202(1): 149-150, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32191842
17.
Pulse Wave Velocity in Chronic Obstructive Pulmonary Disease and the Impact of Inhaled Therapy (SUMMIT): A Randomized Double-Blind Clinical Trial.
Am J Respir Crit Care Med
; 201(10): 1307-1310, 2020 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32017597
18.
One-year change in health status and subsequent outcomes in COPD.
Thorax
; 70(5): 420-5, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25782757
19.
Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team.
Am J Respir Crit Care Med
; 189(9): 1022-30, 2014 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24552242
20.
ADRB2 p.Thr164Ile association with hospitalization depends upon asthma severity.
J Allergy Clin Immunol
; 143(5): 1962-1965.e4, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30682460